NCT05185999View on ClinicalTrials.gov

Icodextrin Study to Test Short-Term Safety, Tolerability and Preliminary Efficacy of Sodium-Free Solution in PD Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

October 20, 2023

Study Completion Date

October 20, 2023

Conditions
Chronic Kidney Failure
Interventions
DRUG

Icodextrin/Dextrose

Single 8 hour dwell of a 500mL intraperitoneal sodium-free 30% Icodextrin / 10% Dextrose solution

Trial Locations (2)

N6A 5W9

Victoria Hospital, London Health Sciences Centre, London

N6K 1M6

Westmount Kidney Care Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER